Staddon J M, Hansford R G
Biochem J. 1987 Feb 1;241(3):729-35. doi: 10.1042/bj2410729.
Phenylephrine, vasopressin and glucagon each increased the amount of active (dephospho) pyruvate dehydrogenase (PDHa) in isolated rat hepatocytes. Treatment with 4 beta-phorbol 12-myristate 13-acetate (PMA) opposed the increase in PDHa caused by both phenylephrine and glucagon, but had no effect on the response to vasopressin: PMA alone had no effect on PDHa. As PMA is known to prevent the phenylephrine-induced increase in cytoplasmic free Ca2+ concentration ([Ca2+]c) and to diminish the increase [Ca2+]c caused by glucagon, while having no effect on the ability of vasopressin to increase [Ca2+]c, these data are consistent with the notion that in intact cells an increase in [Ca2+]c results in an increase in the mitochondrial free Ca2+ concentration, which in turn leads to the activation of PDH. In the presence of 2.5 mM-Ca2+, glucagon caused an increase in NAD(P)H fluorescence in hepatocytes. This increase is taken to reflect an enhanced activity of mitochondrial dehydrogenases. PMA alone had no effect on NAD(P)H fluorescence; it did, however, compromise the increase produced by glucagon. When the extracellular free [Ca2+] was decreased to 0.2 microM, glucagon could still increase NAD(P)H fluorescence. Vasopressin also increased fluorescence under these conditions; however, if vasopressin was added after glucagon, no further increase in fluorescence was observed. Treatment of the cells with PMA resulted in a smaller increase in NAD(P)H fluorescence on addition of glucagon: the subsequent addition of vasopressin now caused a further increase in fluorescence. Changes in [Ca2+]c corresponding to the changes in NAD(P)H fluorescence were observed, again supporting the idea that [Ca2+]c indirectly regulates intramitochondrial dehydrogenase activity in intact cells. PMA alone had no effect on pyruvate kinase activity, and the phorbol ester did not prevent the inactivation caused by glucagon. The latter emphasizes the different mechanisms by which the hormone influences mitochondrial and cytoplasmic metabolism.
去氧肾上腺素、血管加压素和胰高血糖素均可增加离体大鼠肝细胞中活性(脱磷酸化)丙酮酸脱氢酶(PDHa)的含量。用4β-佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)处理可对抗去氧肾上腺素和胰高血糖素引起的PDHa增加,但对血管加压素的反应无影响:单独使用PMA对PDHa无影响。由于已知PMA可阻止去氧肾上腺素诱导的细胞质游离Ca2+浓度([Ca2+]c)升高,并减少胰高血糖素引起的[Ca2+]c升高,而对血管加压素升高[Ca2+]c的能力无影响,这些数据与以下观点一致,即在完整细胞中,[Ca2+]c升高导致线粒体游离Ca2+浓度升高,进而导致PDH激活。在2.5 mM - Ca2+存在下,胰高血糖素可导致肝细胞中NAD(P)H荧光增加。这种增加被认为反映了线粒体脱氢酶活性增强。单独使用PMA对NAD(P)H荧光无影响;然而,它确实会损害胰高血糖素产生的荧光增加。当细胞外游离[Ca2+]降至0.2 μM时,胰高血糖素仍可增加NAD(P)H荧光。在这些条件下血管加压素也可增加荧光;然而,如果在胰高血糖素后添加血管加压素,则未观察到荧光进一步增加。用PMA处理细胞后,添加胰高血糖素时NAD(P)H荧光增加较小:随后添加血管加压素现在导致荧光进一步增加。观察到与NAD(P)H荧光变化相对应的[Ca2+]c变化,再次支持了[Ca2+]c间接调节完整细胞线粒体内脱氢酶活性的观点。单独使用PMA对丙酮酸激酶活性无影响,佛波醇酯也不能阻止胰高血糖素引起的失活。后者强调了激素影响线粒体和细胞质代谢的不同机制。